NEPT - Neptune Technologies & Bioressources Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

2.72

0.00 (0.00%)

As of 3:40PM EDT. Market open.

Stock chart is not supported by your current browser

Previous Close	2.72
Open	2.73
Bid	2.70 x 2600
Ask	2.72 x 200
Day's Range	2.67 - 2.75
52 Week Range	0.70 - 3.59
Volume	196,063
Avg. Volume	687,995

Market Cap	215.448M
Beta	1.49
PE Ratio (TTM)	43.87
EPS (TTM)	0.06
Earnings Date	Jan 10, 2017 - Jan 16, 2017
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	2008-07-24
1y Target Est	3.15

Trade prices are not sourced from all markets

All

News

Press Releases

Marketwired2 months ago
Neptune Announces Third Quarter Results
Q3 Financial and Operational Highlights for the 3-month period ended December 31, 2017 compared to the 3-month period ended November 30, 2016
ACCESSWIRE2 months ago
Neptune Technologies & Bioressources Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT ) will be discussing their earnings results in their Q3 Earnings Call to be held on February 14, ...
Motley Fool2 months ago
Here's Why Neptune Technologies & Bioressources Inc. Rose as Much as 14% Today
The tiny marijuana stock announced a new partnership.
Marketwired2 months ago
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
Tetra Bio-Pharma Inc. and Neptune Technologies & Bioressources Inc. today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based ...
Marketwired2 months ago
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
Neptune Technologies & Bioressources Inc. and Tetra Bio-Pharma Inc. today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based ...
Marketwired3 months ago
Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017
Neptune Technologies & Bioressources Inc. , announces that it will be holding a conference call on February 14, 2018 at 5:00 PM to discuss its third quarter results for the interim period ended December ...
ACCESSWIRE3 months ago
Wired News – Neptune Signs Exclusive Research Agreement for Developing New Medical and Wellness Cannabinoid-Based Products
LONDON, UK / ACCESSWIRE / January 22, 2018 / Active-Investors.com has just released a free research report on Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT ) ("Neptune"). If you want ...
Marketwired3 months ago
Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products
Neptune Technologies & Bioressources Inc. today announced an exclusive research agreement with the purpose of developing new medical and wellness targeted cannabinoid-based products,...
Marketwired3 months ago
Neptune makes its recommendations on Bill 157 special consultations at the National Assembly
Neptune Technologies & Bioressources Inc. is pleased to announce that it will participate in special consultations on Bill 157, regulating cannabis. Michel Timperio, President of the Cannabis Business ...
TheStreet.com4 months ago
Anyone Who Resists the Rise of Legal Cannabis Is Among Dumbest on Wall Street
You don't have to be a stoner to realize that legal cannabis is an industry ripe for profit. Here are two companies that could profit from a push into the legal weed game.
Marketwired4 months ago
Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®
Neptune Technologies & Bioressources Inc. announces, in partnership with Charles R. Poliquin's Strength Sensei Nutraceuticals, the launch of MaxSimil enhanced Omega Drive omega-3 EPA and DHA product for ...
Marketwired5 months ago
Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements
Neptune Technologies & Bioressources Inc. , announces that on November 28, 2017 it received notification from Nasdaq Listing Qualifications Department confirming that the Company has regained compliance ...
Marketwired5 months ago
Highlights of Neptune's Investor Conference Being Held in New York Today
Neptune Technologies & Bioressources Inc. , is holding its Investor Conference in New York City to present its "Cannabis Business Roadmap". Management presentations will start at 8.00 a.m. EST ...
Capital Cube5 months ago
Neptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentals
Categories: Yahoo FinanceNeptune Technologies & Bioresources, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 63. Our analysis is based on comparing Neptune Technologies & Bioresources, Inc. with the following peers – Cipher Pharmaceuticals Inc., Novelion Therapeutics Inc., TerraVia Holdings, Inc. and ChromaDex Corporation (CPH-CA, NVLN-US, TVIAQ-US and CDXC-US). Neptune Technologies & Bioresources, ... Read more (Read more...)
Marketwired5 months ago
Neptune Announces Second Quarter Results
Q2 Financial and Operational Highlights for the 3-month period ended September 30, 2017 compared to the 3-month period ended August 31, 2016
Marketwired5 months ago
Acasti Pharma Reports Second Quarter FY 2018 Financial Results
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, ...
Marketwired6 months ago
Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, ...
Marketwired6 months ago
Neptune to Hold Business Update Meeting on November 28, 2017
Neptune Technologies & Bioressources Inc. , will hold a business update meeting in New York City on November 28, 2017 from 8:00 AM to 10:00 AM to discuss its entry into the legal cannabis market in Canada ...
Marketwired6 months ago
Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017
Neptune Technologies & Bioressources Inc. , announces that it will be holding a conference call on November 14, 2017 at 5:00 PM to discuss its second quarter results for the interim period ended September ...
Marketwired7 months ago
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
Acasti Pharma Inc. announces that in accordance with the terms of its outstanding convertible debentures in the total aggregate principal amount of $2,000,000 issued on February 21, 2017 , the Corporation ...
Marketwired7 months ago
Neptune announces appointments for its Cannabis Business
Neptune Technologies & Bioressources Inc. today announced the appointment of Michel Timperio as President and Melody Harwood as Head of Scientific & Regulatory Affairs of its new Cannabis Business. Mr. ...
Capital Cube7 months ago
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017
Categories: Yahoo FinanceGet free summary analysis Neptune Technologies & Bioresources, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Neptune Technologies & Bioresources, Inc. – Cipher Pharmaceuticals Inc., Novelion Therapeutics Inc. and ChromaDex Corporation (CPH-CA, NVLN-US and CDXC-US) that have also reported for this period. ... Read more (Read more...)